Bioengineered products called wound care biologics are used to treat non-healing lower extremity wounds. As early treatment of diabetic ulcers can prevent serious complications like infection, hospitalization, and amputation, demand for wound care biologic products is anticipated to rise dramatically. Since the commercially available skin substitutes offer clinical and scientific proof of efficacy in wound healing, the market for wound care biologics is anticipated to grow significantly.
Biochemically active substances, such as active Wound Care Biologics produced from plants that have anti-inflammatory, antibacterial, or antioxidant properties, may be applied as part of biologic wound healing therapies, which aim to facilitate the restoration of the body's own repair mechanisms.
